Skip to main content

3 fraction APBI brachytherapy - next step in hypofractionation

November 19, 2021

9:00 AM - 10:00 AM (UTC/GMT +08:00 - Asia / Hong Kong)

Registrations are closed

APBI using multi-catheter brachytherapy is currently the only method of breast irradiation with a treatment duration of merely 4–5 days with level 1 evidence showing it to be a valid treatment alternative to WBI after breast conserving surgery (BCS) for low-risk breast cancer patients used in clinical routine.1

Studies continue into the use of brachytherapy to further reduce the number of fractions treated for APBI.2

We invite you to a presentation with Dr. Yaw Chin, Radiation Oncologist at The St George Cancer Care Centre at St George Hospital in Australia. Dr Chin will discuss a prospective, single arm, phase II non-inferiority clinical trial to investigate: 

  • if a three dose schedule of partial breast radiation using multi-catheter interstitial brachytherapy is feasible and comparable to a ten dose schedule in terms of the risk of tumor returning in the same breast.
  • potential treatment-related side effects. 
  • cosmetic outcomes.3

Don't miss this opportunity to learn more about the 3 fraction APBI brachytherapy.  


1 Strnad et al., (V. Strnad). Radiotherapy and Oncology 128 (2018) 411–420 

2 Khan et al, Int J Radiation Oncol Biol Phys, Vol. 104, No. 1, pp. 67e74, 2019 

3 HEARTBEAT Study, St. George Hospital/Sydney, December 2020 

For this webinar, we will be using the platform MS Teams. For information on how they handle your data, please visit This webinar will be recorded and registered attendees will receive a copy of the recording after the webinar has taken place. For information on how Elekta handles your data, please visit

Please note times are in Hong Kong Time (HKT).


Start: November 19, 2021
9:00 AM (UTC/GMT +08:00 - Asia / Hong Kong)
End: November 19, 2021
10:00 AM (UTC/GMT +08:00 - Asia / Hong Kong)

Online event

Detected timezone